Literature DB >> 33879331

Acquired Idiopathic Stiffness After Contemporary Total Knee Arthroplasty: Incidence, Risk Factors, and Results Over 25 Years.

Aaron R Owen1, Meagan E Tibbo1, Andre J van Wijnen2, Mark W Pagnano1, Daniel J Berry1, Matthew P Abdel1.   

Abstract

BACKGROUND: Acquired idiopathic stiffness (AIS) remains a common failure mode of contemporary total knee arthroplasties (TKAs). The present study investigated the incidence of AIS and manipulation under anesthesia (MUA) at a single institution over time, determined outcomes of MUAs, and identified risk factors associated with AIS and MUA.
METHODS: We identified 9771 patients (12,735 knees) who underwent primary TKAs with cemented, modular metal-backed, posterior-stabilized implants from 2000 to 2016 using our institutional total joint registry. Mean age was 68 years, 57% were female, and mean body mass index was 33 kg/m2. Demographic, surgical, and comorbidity data were investigated via univariate Cox proportional hazard models and fit to an adjusted multivariate model to access risk for AIS and MUA. Mean follow-up was 7 years.
RESULTS: During the study period, 456 knees (3.6%) developed AIS and 336 knees (2.6%) underwent MUA. Range of motion (ROM) increased a mean of 34° after the MUA; however, ROM for patients treated with MUA was inferior to patients without AIS at final follow-up (102° vs 116°, P < .0001). Significant risk factors included younger age (HR 2.3, P < .001), increased tourniquet time (HR 1.01, P < .001), general anesthesia (HR 1.3, P = .007), and diabetes (HR 1.5, P = .001).
CONCLUSION: Acquired idiopathic stiffness has continued to have an important adverse impact on the outcomes of a subset of patients undergoing primary TKAs. When utilized, MUA improved mean ROM by 34°, but patients treated with MUA still had decreased ROM compared to patients without AIS. Importantly, we identified several significant risk factors associated with AIS and subsequent MUA. LEVEL OF EVIDENCE: Level III, retrospective comparative study.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  arthrofibrosis; contracture; manipulation under anesthesia (MUA); range of motion (ROM); stiffness

Mesh:

Year:  2021        PMID: 33879331      PMCID: PMC8292170          DOI: 10.1016/j.arth.2021.03.051

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.435


  42 in total

1.  Manipulation of total knee replacements. Is the flexion gained retained?

Authors:  C N Esler; K Lock; W M Harper; P J Gregg
Journal:  J Bone Joint Surg Br       Date:  1999-01

2.  Stiffness after total knee arthroplasty. Prevalence of the complication and outcomes of revision.

Authors:  Jane Kim; Charles L Nelson; Paul A Lotke
Journal:  J Bone Joint Surg Am       Date:  2004-07       Impact factor: 5.284

3.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

Authors:  R A Deyo; D C Cherkin; M A Ciol
Journal:  J Clin Epidemiol       Date:  1992-06       Impact factor: 6.437

4.  Maintaining a hip registry for 25 years. Mayo Clinic experience.

Authors:  D J Berry; M Kessler; B F Morrey
Journal:  Clin Orthop Relat Res       Date:  1997-11       Impact factor: 4.176

Review 5.  Arthrofibrosis Associated With Total Knee Arthroplasty.

Authors:  Victor A Cheuy; Jared R H Foran; Roger J Paxton; Michael J Bade; Joseph A Zeni; Jennifer E Stevens-Lapsley
Journal:  J Arthroplasty       Date:  2017-02-14       Impact factor: 4.757

6.  Reasons for Ninety-Day Emergency Visits and Readmissions After Elective Total Joint Arthroplasty: Results From a US Integrated Healthcare System.

Authors:  Matthew P Kelly; Heather A Prentice; Wei Wang; Brian H Fasig; Dhiren S Sheth; Elizabeth W Paxton
Journal:  J Arthroplasty       Date:  2018-02-12       Impact factor: 4.757

7.  Acquired Idiopathic Stiffness After Total Knee Arthroplasty: A Systematic Review and Meta-Analysis.

Authors:  Meagan E Tibbo; Afton K Limberg; Christopher G Salib; Ahmed T Ahmed; Andre J van Wijnen; Daniel J Berry; Matthew P Abdel
Journal:  J Bone Joint Surg Am       Date:  2019-07-17       Impact factor: 5.284

8.  The tourniquet in total knee arthroplasty. A prospective, randomised study.

Authors:  H M Wakankar; J E Nicholl; R Koka; J C D'Arcy
Journal:  J Bone Joint Surg Br       Date:  1999-01

9.  Failure After Modern Total Knee Arthroplasty: A Prospective Study of 18,065 Knees.

Authors:  Michael Pitta; Christina I Esposito; Zhichang Li; Yuo-Yu Lee; Timothy M Wright; Douglas E Padgett
Journal:  J Arthroplasty       Date:  2017-09-25       Impact factor: 4.757

10.  Molecular pathology of human knee arthrofibrosis defined by RNA sequencing.

Authors:  Banu Bayram; Afton K Limberg; Christopher G Salib; Jacob W Bettencourt; William H Trousdale; Eric A Lewallen; Nicolas Reina; Christopher R Paradise; Roman Thaler; Mark E Morrey; Joaquin Sanchez-Sotelo; Daniel J Berry; Andre J van Wijnen; Matthew P Abdel
Journal:  Genomics       Date:  2020-03-05       Impact factor: 5.736

View more
  3 in total

1.  Human outgrowth knee fibroblasts from patients undergoing total knee arthroplasty exhibit a unique gene expression profile and undergo myofibroblastogenesis upon TGFβ1 stimulation.

Authors:  Banu Bayram; Roman Thaler; Jacob W Bettencourt; Afton K Limberg; Kevin P Sheehan; Aaron R Owen; Daniel J Berry; Mark E Morrey; Joaquin Sanchez-Sotelo; Andre J van Wijnen; Amel Dudakovic; Matthew P Abdel
Journal:  J Cell Biochem       Date:  2022-02-28       Impact factor: 4.480

2.  Excellent and Good Results Treating Stiffness with Early and Late Manipulation after Unrestricted Caliper-Verified Kinematically Aligned TKA.

Authors:  Adithya Shekhar; Stephen M Howell; Alexander J Nedopil; Maury L Hull
Journal:  J Pers Med       Date:  2022-02-18

3.  A 92 protein inflammation panel performed on sonicate fluid differentiates periprosthetic joint infection from non-infectious causes of arthroplasty failure.

Authors:  Cody R Fisher; Harold I Salmons; Jay Mandrekar; Kerryl E Greenwood-Quaintance; Matthew P Abdel; Robin Patel
Journal:  Sci Rep       Date:  2022-09-27       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.